PET Scan Not Routinely Recommended for This 7mm Growing Nodule
For a 7mm solid pulmonary nodule that grew from 5mm to 7mm over one year, continued CT surveillance is the appropriate next step rather than PET scan, as the nodule remains below the 8mm threshold where PET imaging becomes useful and the growth pattern warrants closer monitoring rather than functional imaging.
Why PET is Not Indicated at This Size
The critical size threshold across all major guidelines is >8mm for considering PET scan 1, 2. This is not arbitrary—PET has limited spatial resolution and performs poorly for nodules ≤8mm, with high false-negative rates for small lesions regardless of their malignant potential 1, 3, 4. Even recent research confirms that PET metabolic parameters only become discriminatory at 8mm or larger 5.
The Fleischner Society 2017 guidelines explicitly state that for solid nodules 6-8mm, the management pathway is CT surveillance at specific intervals, with PET consideration reserved only for nodules >8mm 6.
The Significance of Growth
The growth from 5mm to 7mm over one year is concerning and increases suspicion for malignancy, but this changes the surveillance intensity, not the modality. According to ACCP guidelines, for nodules measuring >6mm to ≤8mm with risk factors (which growth itself represents), you should:
- Perform CT at 3-6 months (shortened from the standard 6-12 month interval)
- Then repeat at 9-12 months
- Continue at 24 months if stable 1, 2
Recommended Management Algorithm
For this specific 7mm growing nodule:
Repeat low-dose chest CT at 3 months using thin sections (≤1.5mm) 1, 2
If further growth occurs (especially if it crosses 8mm):
- Consider PET/CT to assess metabolic activity
- Consider nonsurgical biopsy if pretest probability is moderate (5-60%)
- Consider surgical diagnosis if highly suspicious features develop 2
If stable at 3 months:
Important Caveats
Risk stratification matters: If this patient has high-risk features (heavy smoking history, upper lobe location, spiculated margins, family history), the 3-month follow-up becomes even more critical 1, 6. The Asian consensus guidelines note that in regions with endemic tuberculosis, PET specificity drops dramatically (as low as 25-61%), making it even less useful for small nodules where infectious etiologies are common 2, 3.
Don't skip ahead: Jumping to PET at 7mm wastes resources and provides unreliable information. A 2007 study showed PET sensitivity drops significantly below 8mm, and false-negatives are common in slow-growing adenocarcinomas and carcinoid tumors—exactly the types that might present as slowly growing small nodules 7.
Volume doubling time: The growth from 5mm to 7mm represents approximately a 2.7-fold volume increase over one year. This doubling time (roughly 12 months) falls in the intermediate range—too slow to be obviously benign (which typically don't grow), but not explosively fast. This reinforces the need for close CT surveillance rather than immediate invasive procedures 1.
The evidence consistently shows that at 7mm, CT surveillance with shortened intervals is the standard of care, with PET reserved for when the nodule crosses 8mm or demonstrates other highly suspicious features 1, 2, 6, 3.